Ovarian Cancer Research Alliance (OCRA) shared a post on LinkedIn:
“The Global Ovarian Cancer Research Consortium and its inaugural AI Accelerator Grant have been making waves across health, science, and business media, reflecting widespread interest in what this work could mean for patients.
The $1 million global research grant, plus an additional $1 million in compute support from Microsoft’s AI for Good Lab, will fund an international team of researchers examining whether artificial intelligence can improve how survival and treatment response are predicted in ovarian cancer.
Other articles about Ovarian Cancer Research Alliance on OncoDaily.